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Abstract
Background: Graphistrength© C100 multiwalled carbon nanotubes (MWCNT) provide superior electrical and
mechanical properties for various applications. The evaluation of the intrinsic hazard properties of Graphistrength©
C100 is an essential step for safe use. A general feature of multiwalled carbon nanotubes after inhalation or
intratracheal exposures is the induction of an inflammatory reaction in the lungs sometimes associated with local
genotoxic effects.
Methods: After investigating different parameters for the aerosol generation and performing a 5-day inhalation
range finding study, male and female Wistar rats were exposed nose-only for 90 days to target concentrations of
0.05, 0.25 and 5.0 mg/m3 air of Graphistrength© C100 and sacrificed 24 h and 90 days after the last exposure.
Broncho-alveolar lavage fluid (BALF) was also collected and analyzed for inflammatory parameters. Twenty-four
hours post-exposure, chromosomal aberrations in the bone marrow cells were evaluated by the micronucleus test
and DNA damages in the lung, kidney and liver cells by both the standard and the human 8-oxoguanine DNA
N-glycosylase 1 (hOGG1)-modified comet assay. All studies were performed according to the OECD test guidelines.
Results: An inflammatory lung reaction and the release of inflammatory factors in the BALF were observed in all
rats exposed to 5.0 mg/m3, associated with changes in the differential white blood cells counts. The slight changes
in BALF parameters at 0.25 mg/m3 recovered and signs of lung clearance of the MWCNT were observed. No
pathological changes were observed on the pleura. Neither increase in the number of micronucleated
polychromatic erythrocytes nor increase in percent DNA damage were observed at any concentration.
Conclusions: Lung inflammation characteristic of an overload with insoluble particles was observed after a 90-day
exposure to 5.0 mg/m3 of Graphistrength© C100. Clear signs of clearance and recovery were observed at 0.25 mg/m3. No
genotoxicity was detected locally in lung and distally in bone marrow, liver and kidney. Therefore, Graphistrength© C100
appears of low concern in term of local and systemic genotoxicity and a No-Observed Adverse Effect Concentration
(NOAEC) of 0.25 mg/m3 (0.28 mg/m3 as actual concentration) was established for the repeated-dose toxicity.
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Background
Multiwalled carbon nanotubes (MWCNT) are emerging
new materials intended for use in aeronautics, automo-
tive, electronics, and many other fields. The outstanding
performance of MWCNT in applications like electrical
conduction or mechanical improvements makes them
valuable in the development of new light materials with
improved properties [1, 2]. There is not just a single
kind of MWCNT. There are diverse materials whose
physico-chemical and toxicological properties depend on
several factors: number of walls, diameter, length, shape
(needle-like shape or flexible and contorted), states of
agglomeration and aggregation, surface chemistry, me-
tallic impurities, to name a few. Determination of the
potential health effects of MWCNT has become a focus
of attention in the scientific and regulatory community.
The possible impact on the health of workers involved
in manufacture and handling and the development of
wide spread use including a number of consumer uses
[3] prompted studies of various materials using different
routes of exposure. The similarity in the shape and di-
mension of some kinds of MWCNT and asbestos was
reported by Poland in 2008 [4]. Toxicology studies con-
firmed the induction of inflammation, granulomas and/
or mesotheliomas by a long, thick and rigid (needle-like)
type of MWCNT (MWCNT-7 from Mitsui, diameter
70-170 nm, length ca. 5 μm) after intraperitoneal (i.p.)
injection to p53+/- mice [5, 6] and Fischer 344/Brown
Norway F1 hybrids rats [7], injection into the pleural
space of C57Bl/6 mice [8], and intrascrotal injection to
Fischer 344 rats [9]. Inhalation exposure of male
B6C3F1 mice to MWCNT-7 for 15 days at a concentra-
tion of 5 mg/m3 promoted bronchioloalveolar adenoma
and carcinoma induced by a single i.p. injection of meth-
ylcholanthrene [10]. MWCNT-7 was also found to in-
duce oxidative DNA damages and gene mutations in the
lung cells of mice after a single intratracheal (i.t.) instilla-
tion [11]. In contrast, no fibrotic lesions were observed
[8] after the intrapleural injection to C57Bl/6 mice of
short and straight (diameter 20-30 nm, length 0.5-2 μm,
from Nanostructured & Amorphous Materials, Inc.) or
curled/tangled (diameter ca. 15 nm, length 1-5 μm and
diameter ca. 10 nm, length 5-20 μm, both from NanoLab
Inc.) MWCNT. Moreover, no increased incidence of
mesothelioma and other tumors was recorded by Muller
et al. [12] in male Wistar rats two years after a single i.p.
injection of MWCNT (diameter ca 10 nm, length
0.7 μm, from Namur University) with or without struc-
tural defects. No induction of malignant mesothelioma
in the peritoneal cavity [13] was also observed when rats
were followed for up to 3 years after two i.p. injections
of a tangled form of MWCNT (diameter 15 nm, length
3 μm, from Showa Denko [7]). Therefore, it seems that
the rigidity, diameter, length, surface properties and
possibly contaminant metals are key factors when consid-
ering the potential for a carcinogenic effect of MWCNT
[13]. In view of the lack of coherent evidence across the
various distinct MWCNT, the IARC Monograph Working
Group [14] specifically classified MWCNT-7 as possibly
carcinogenic to humans (Group 2B) and the other types of
MWCNT were categorized as not classifiable in respect to
their carcinogenicity to humans (Group 3).
Graphistrength© C100 is one of the industrial MWCNT
referenced in the sponsorship program for the safety test-
ing of nanomaterials by the Organization for Economic
Cooperation and Development (OECD) [15]. There are a
number of publications [16–25] reporting studies on
Graphistrength© C100 under the coded named NM 402
or JRCNM04002a, sample from the repository of the
European Commission Joint Research Centre (EU-JRC)
[26]. This EU-JRC Graphistrength© C100 was produced by
Arkema in a pilot production unit, whereas, the Graphis-
trength© C100 used in the present 90-day study was from
an industrial production unit. Nevertheless, these two units
used the same process of synthesis and there are no signifi-
cant physico-chemical differences between the products
from both production units.
Graphistrength© C100 is formed of large MWCNT ag-
glomerates with a mean particle size of about 400 μm and
contains a residual amount (<0.23 %) of small agglomerates
(<15 μm) [27]. These small particles are comparable to
those observed by R’mili et al. [28] in the atmosphere of
our high safety laboratory dedicated to scientific experi-
ments with MWCNT, indicating a possible inhalation ex-
posure to these small particles. Therefore, conducting an
inhalation subchronic toxicity study was judged to be a key
feature in the safety assessment of Graphistrength© C100.
However, Graphistrength© C100 does not contain sufficient
quantities of these small agglomerates to directly provide
the test material necessary for an experimental inhalation
study [27]. Thus an aerosol generation procedure, as re-
ported in the additional file 1, was developed in order to
perform a valid study which fulfils the requirement of the
inhalation specific OECD test guidelines [29]. The micron-
isation process is an enrichment of the small particle frac-
tion and is allowing the worst case material to be used as
expected by the regulatory authorities [30]. Another im-
portant criterion was ensuring that the administered aero-
sol has physico-chemical properties similar to the original
material. After a careful evaluation, the defined technical
conditions for the generation of Graphistrength© C100
aerosols were assessed in a 5-day range finding inhalation
toxicity study in rats with a 28-day recovery period. Then, a
90-day inhalation toxicity study was performed in rats. It
included a 90-day recovery period and an evaluation of the
pulmonary inflammation parameters. This subchronic
study also provided the opportunity to perform a micronu-
cleus assay on the bone marrow cells, as well as, a standard
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and a hOGG1-modified comet assay on the lung, liver and
kidney cells of the exposed rats. The hOGG1-modified
comet assay was chosen because it is more specific than the
FPG (formamidopyrimidine glycosilase) comet assay for the
identification of oxidative DNA damage [31]. Thus, the
genotoxic potential was evaluated in the cells directly in
contact with Graphistrength© C100, and at a distance in
case material was translocated from the lungs.
Results
Physico-chemical analysis
Graphistrength© C100 used in the 5-day (batch no. 8287)
and the 90-day (batch no. 110329-018) studies have respect-
ively a median agglomerate size distribution of 376 and
418 μm, an ash content of about 8.6 and 8.2 %, an apparent
density of 0.085 and 0.106 g/cm3, a specific surface area of
187 and 225.6 m2/g and metal contents (from the catalyst)
of 3.2 and 3.0 % for Al and 2.7 and 2.7 % for Fe. MWCNT
constituents of Graphistrength© C100 have respectively
11 ± 3 and 12 ± 4 walls with an outer mean diameter of
11.8 and 12.1 nm, and a length of 1.05 ± 0.67 and 1.07 ±
1.10 μm. The surface to volume ratio of the material used
for the 90-day study was 2.4 × 107 m-1. The other physico-
chemical data are presented in Additional file 1: Table S3.
The physico-chemical characterizations of Graphis-
trength© C100 (batch no. 110329-018) after a 12-h mill-
ing under argon and after aerosol generation (samples
collected at the exhaust of the elutriator just before the
inhalation chamber) are detailed in the Additional file 1:
Table S3 and Additional file 1: Figure S4 and showed min-
imal changes between the starting material and the ball
milled and micronized samples.
Characterization of the aerosol during exposures
The gravimetrically determined mean achieved aerosol
concentrations of 0.066, 0.26 and 1.30 mg/m3 air during
the 5-day exposure study were close to the targets of
0.05, 0.25 and 1.25 mg/m3 (Additional file 1: Table S4), re-
spectively. Over the 90-day exposure, the mean achieved
aerosol concentrations of 0.06, 0.28 and 4.84 mg/m3 air
were also close to the target concentrations of 0.05, 0.25
and 5.0 mg/m3, respectively (Table 1).
The mean mass median aerodynamic diameters (MMAD)
and geometric standard deviations (GSD) by impactor/gravi-
metric determinations during the 5-day and 90-day expo-
sures were within the target ranges (Additional file 1: Table
S4 and Table 1). The count median aerodynamic diameters
(CMAD) determined by Wide Range Particle Spectrometer©
(WPRS) analysis (Table 1) were similar between the exposed
groups of the 90-day exposure study. All together these data
showed that the generated aerosols were within the respir-
able range for rats (MMAD< 3 μm).
Temperature, relative humidity and oxygen parameters
were consistent during both treatment periods (Additional
file 1: Table S4 and Table 1, respectively). In addition,
values for temperature and oxygen concentration were
similar across all groups. Dried air was used for aerosol
generation and, accordingly, the relative humidity values
were below 8 % for all groups. Differences between the
groups were considered to be negligible at this level.
Therefore, the exposure conditions were considered to be
satisfactory for this type of studies.
Ante-mortem animal observations
5-day exposure with a 28-day recovery period
All animals survived the 5-day exposure and 28-day recov-
ery periods without showing clinical signs (data not shown).
The food intake was similar across all groups during the
study and there were no effects on body weight that were
considered to be related to exposure to Graphistrength©
C100. Stagnation of body weight gain or marginal body
weight loss was noted between day 1 and day 5 of treatment
for all groups including controls. It is not unusual in inhal-
ation studies and was considered to be due to the restraining
of the animals in the tubes during the nose-only exposure
procedure and not related to treatment with the test mater-
ial. Normal body weight gain was observed during the 28-
day recovery period across all groups (data not shown).
90-day exposure with a 90-day recovery period
All animals survived the 90-day exposure and recovery pe-
riods. There were no test-item related clinical signs in any
group. Hair loss, scabs, erythema and localized swelling
were recorded. These signs are commonly seen in animals
of this age and strain and are, therefore, considered to be
incidental. No effects on food consumption were observed
during the 90-day treatment. Increased food intake was re-
corded in male rats exposed to 0.05 and 5.0 mg/m3 during
the first week of the 90-day recovery and several weeks
thereafter. In addition increased food intake was recorded
during the first two weeks of recovery in females exposed
to 5.0 mg/m3 (data not shown). Slightly reduced body
weight gains were seen in males and females exposed to
0.25 and 5.0 mg/m3 during several weeks of exposure. How-
ever, the mean body weights of these animals remained
similar to the control group during the exposure period. At
0, 0.05, 0.25, and 5.0 mg/m3, the body weights (means ±
SDs) were at the commencement of study (day 0): 266.8 ±
11.9 g, 269.7 ± 9.9 g, 268.5 ± 12.2 g and 270.4 ± 11.0 g in
males (35 rats per group), respectively and 170.7 ± 19.1 g,
170.8 ± 16.0 g, 174.3 ± 19.4 g and 177.9 ± 22.7 g in females
(35 per group), respectively. At the end of the 90-day expos-
ure period, the respective body weights were 401.7 ± 26.9 g,
407.3 ± 35.9 g, 405.3 ± 37.9 g and 411.2 ± 29.4 g in males (30
per group) and 244.7 ± 21.9 g, 240.3 ± 20.3 g, 248.0 ± 25.4 g
and 245.9 ± 25.3 g in females (30 per group). Increased body
weight gains in males and females and body weights in
males were observed during recovery in animals exposed to
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5.0 mg/m3. At 0, 0.05, 0.25, and 5.0 mg/m3, the respective
body weights (means ± SDs) at the end of the 90-day recov-
ery period were 494.5 ± 44.1 g, 529.0 ± 53.5 g, 518.8 ± 55.0 g
and 539.3 ± 40.6 g in males (20 per group) and 297.1 ±
33.9 g, 290.2 ± 30.0 g, 298.5 ± 39.8 g and 302.4 ± 45.5 g in fe-
males (20 per group). None of these changes were consid-
ered to be adverse effects.
There were no effects of exposure on grip strength,
body temperature, landing foot splay and locomotors ac-
tivity. There were no differences in blood pressure that
were considered to be related to the exposure. High sys-
tolic/diastolic blood pressures (ca. 140/100 mmHg) were
observed in one male of each control and treated
groups. No effect was recorded during ophthalmoscopic
examination (data not shown).
The statistically significant changes observed in
hematological parameters are summarized in Table 2.
An increase in relative and absolute neutrophil counts
and a slight decrease of the relative (but not absolute)
lymphocyte counts were recorded in males and females
exposed to 5.0 mg/m3 at the end of the 90-day exposure
and recovery periods. The other statistically significant
changes (relative eosinophil counts, prothrombin time,
and platelets) were all in the range of the historical con-
trol data (HCD) of the laboratory (Table 2), not-dose-
related, observed only in one sex and not observed after
the 90-day treatment free period and therefore were not
considered to be treatment-related.
The statistically significant changes of the blood chem-
istry parameters are summarized in Table 3. Increased
potassium values were recorded in males exposed to
5.0 mg/m3 (9 %) and in all treated groups of females (15,
21 and 11 % at 0.05, 0.25 and 5.0 mg/m3, respectively) at
the end of the treatment period but not after the 90-day
treatment free period. Considering the low magnitude of
this hyperkalemia and the variability of the potassium
levels in the rats [32], these changes were not considered
to be treatment related and/or adverse. The other statisti-
cally significant changes (creatinine, triglycerides, sodium,
chloride, calcium, and proteins) were not considered to be
treatment-related as the values were all in the range of the
HCD data (Table 3), not dose-related, observed only in
one sex, and not correlated with histological findings.
Urinalysis and estrus cycles parameters were unre-
markable (data not shown).
Post-mortem animal observations
Bronchoalveolar lavage fluid (BALF) analysis
Detailed results of cellular, biochemical and cytokines
measurements are displayed in Additional file 1: Tables
S5 and Additional file 1: Table S6 for the 5-day study
and Tables 4, 5, 6 for the 90-day study. As the methods
used to collect of the BALF were slightly different be-
tween the 5-day (use of the full lung) and the 90-day
(use of only the left lobe) studies, and to also allow a
comparison with the recovery data, changes in BALF pa-
rameters presented in Additional file 1: Figure S5 (5-day
study) and Figs. 1 and 2 (90-day study) were normalized
relative to the time-matched, concurrent control group.
5-day exposure with a 28-day recovery period
Twenty-four hours post exposure, the differential cell
count in BALF revealed statistically significantly in-
creased polymorphonuclear neutrophils (PMN) levels at
1.25 mg/m3 (x9 compare to control group) as detailed in
Additional file 1: Table S5 and Additional file 1: Figure
Table 1 Target and achieved aerosol concentrations and particles size of Graphistrength© C100. Temperature, relative humidity and
oxygen concentration measured over the 90-day exposure period
Groups Control Low Mid High
Target aerosol concentrations (mg/m3 air) 0 0.05 0.25 5.0
Achieved aerosol concentrations (mg/m3 air) - 0.06 ± 0.04 0.28 ± 0.06 4.84 ± 0.41
Mean mass median aerodynamic diameter (MMAD, μm) (gravimetric determination) - nda 1.62 ± 0.39 2.30 ± 0.34
(n = 5) (n = 14)
Mean GSD (gravimetric determination) - nda 4.67 ± 4.81 2.47 ± 0.26
Mean percentage of particles < 3 μm (gravimetric determination) - nda 74.10 ± 14.00 63.49 ± 6.23
Count median aerodynamic diameter (CMAD, nm) (WPRS determination) - 196.2 ± 54.7 231,5 ± 65.1 208.0 ± 62.0
(n = 14) (n = 14) (n = 14)
Mean temperature (°C) 23.2 ± 0.9 23.3 ± 0.7 23.6 ± 0.7 23.8 ± 0.6
Mean relative humidity (%) 5.8 ± 1.5 6.1 ± 1.7 6.1 ± 1.7 6.3 ± 1.6
Mean oxygen concentration (%) 20.8 ± 0.0 20.8 ± 0.0 20.8 ± 0.0 20.8 ± 0.0
nd: not determined
a at 0.05 mg/m3 due to the very low concentration, the particle size could not be determined by gravimetry at an air flow rate of 1 L/min. The aerosol
concentrations at 0.05 and 0.25 mg/m3 were achieved by serial dilution with compressed, filtered, dry air of the 0.25 and 5.0 mg/m3 concentrations, respectively.
Therefore, the MMAD and GSD at 0.05 mg/m3 are expected to be of the same order as at 0.25 mg/m3. This is also confirmed by particle size data from the 5-day
study with sampling at an air flow rate of 9 L/min (see Additional file 1: Table S4 for details)
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S5 panel A. After the 28-day recovery period the PMN
value was similar to controls (Additional file 1: Table S5
and Additional file 1: Figure S5 panel B). Twenty-four
hours post exposure, the macrophages in all treated
groups contained phagocytized test material with a
dose-related increased incidence (Additional file 1: Table
S5). At the end of the recovery period, the incidence sig-
nificantly decreased at all concentrations (Additional file
1: Table S5).
Biochemical analysis of the BALF 24 h post-exposure
resulted in statistically significantly increased γ-
glutamyltransferase (GGT) levels at 1.25 mg/m3 (x3.5)
and increased protein values at 0.25 (x23) and 1.25
(x20) mg/m3 (Additional file 1: Table S6 and Additional
file 1: Figure S5 panel A). After the 28-day recovery
period, differences to controls diminished and statistical
significance was only observed for changes in protein
values at 0.25 (x3) and 1.25 (x3.5) mg/m3 (Additional
file 1: Table S6, Additional file 1: Figure S5 panel B). All
other changes between exposed and control groups and
between the 24-h-and 28-day sacrifice times are just
biological variations.
90-day exposure with a 90-day recovery period
Twenty-four hours post exposure, there were no changes
in BALF total cell count and viability in males (Table 4,
Fig. 1 panel a). Nevertheless, it must be mentioned that
these 2 parameters have been determined in only 4 out
of 10 males rats exposed at 5.0 mg/m3 due to the large
amount of black particles and MWCNT-laden BAL cells
Table 2 Statistically significant changesa in hematological parameters 24 h and 90 days after a 90-day exposure of male and female
rats to Graphistrength© C100
Concentration Total leucocytes Neutrophils Eosinophils Lymphocytes Prothrombin time Platelets
(mg/m3) G/L rel. 1 (G/l) rel. 1 (G/l) rel. 1 (G/l) rel. 1 (sec) G/l
MALE
HCD b, c 3.74 - 9.53 0.119 - 0.339 0.01 - 0.035 0.611 - 0.842 0.70 – 0.97 708 - 1168
(0.66 - 2.29) (0.05 - 0.22) (2.59 - 7.39) (14.4 - 29.9)
24 h post exposure
0 6.43 0.197 (1.28) 0.009 (0.06) 0.742 (4.78) 0.73 (23.4) 879
0.05 7.01 0.220 (1.79) 0.013 (0.10) 0.716 (4.79) 0.73 (23.4) 973
0.25 7.30 0.211 (1.71) 0.013* (0.10) 0.727 (5.15) 0.76 (22.8) 972
5.0 8.13 0.327** (2.63**) 0.015* (0.12) 0.608** (5.05) 0.77* (22.5) 1003*
90 days post exposure
0 7.07 0.237 (1.79) 0.012 (0.09) 0.707 (4.88) 0.85 (23.7) 903
0.05 7.47 0.223 (1.62) 0.014 (0.11) 0.716 (5.44) 0.86 (23.4) 914
0.25 7.14 0.283 (2.23) 0.015 (0.11) 0.664 (4.55) 0.85 (23.7) 822
5.0 8.23 0.374* (2.96**) 0.015 (0.12) 0.577* (4.84) 0.89 (22.8) 901
FEMALE
HCDb, c 1.91 - 6.14 0.099 - 0.343 0.009 - 0.045 0.598 - 0.860 0.70 – 0.98 723 - 1235
(0.34-1.31) (0.03 - 0.15) (1.30 - 4.86) (13.5 - 38.2)
24 h post exposure
0 4.07 0.146 (0.61) 0.011 (0.04) 0.809 (3.29) 0.73 (23.5) 1144
0.05 4.05 0.152 (0.61) 0.006 (0.04) 0.808 (3.27) 0.75 (23.0) 1087
0.25 3.69 0.170 (0.62) 0.016 (0.06) 0.779 (2.87) 0.79** (22.2**) 1042
5.0 4.96 0.261** (1.21**) 0.012 (0.06) 0.698** (3.54) 0.77 (22.6) 1099
90 days post exposure
0 4.17 0.175 (0.67) 0.017 (0.06) 0.772 (3.27) 0.87 (23.2) 883
0.05 3.75 0.220 (0.84) 0.019 (0.07) 0.729 (2.71) 0.88 (22.8) 933
0.25 3.32 0.238* (0.74) 0.018 (0.05) 0.714 (2.40) 0.86 (23.5) 841
5.0 4.90 0.382** (1.81**) 0.013 (0.07) 0.564** (2.85) 0.89 (22.7) 914
* p < 0.05, ** p < 0.01; statistical significant differences to controls
a No statistically significant changes were observed at any concentrations and time-points on red blood cell, hemoglobin, hematocrit, mean corpuscular volume,
mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, reticulocytes, basophils, monocytes and partial thromboplastine time
b HCD Historical control data, 95 % tolerance limits
c Changes statistically significant outside the HCD are in italic characters
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in the cellular suspension. In females, the total cell count
was increased at 5.0 mg/m3 (+78 %) while viability did
not show any differences (Table 4, Fig. 1 panel b. The
cytodifferentiation of BALF cells (Table 4, Fig. 1) showed
decreases in macrophages and increases in neutrophils
and lymphocytes in males and females exposed to 0.25
and 5.0 mg/m3, respectively.
Statistically significant increases in protein (x4.3 and
x3.7), phospholipids (x6.6 and x4.8), LDH (x6.6 and
x6.2), GGT (x3.3 and x 3.1) and ALP (x5.2 and 4.1) were
recorded in males and females exposed at 5.0 mg/m3, re-
spectively (Table 5, Fig. 1). In addition phospholipids in
males (x2.2) and GGT in males (x2.1) and females (x2.4)
were also increased at 0.25 mg/m3.
A statistically and biologically significant increase
(values higher than mean + 2 SD of the corresponding
control group) of tumor necrosis factor alpha (TNF-α)
was observed in BALF of male and female rats exposed
to 0.25 (x3.4 and x8.5, respectively) and 5.0 mg/m3 (x6.1
and x10, respectively) and of IL-1β levels (x1.8) in fe-
males exposed to 5.0 mg/m3 (Table 6, Fig. 1). Detectable
levels of IL-5 and IL-1α (data not shown) were measured
in some single animals (including controls) without a
dose-response relationship.
Ninety days post-exposure, there was an increase in
the total cell counts in male and female rats exposed to
5.0 mg/m3 (x3.5 and x2.4, respectively) but viabilities
were not affected (Table 4, Fig. 2). Differential counts
were still changed with a similar intensity as 24-h post-
exposure. In males exposed to 0.25 mg/m3, an increase
of the total cell count (+58 %) was observed, but it was
not present 24 h post-exposure. As this increase was
not associated with changes in differential counts, bio-
chemistry parameters, and lung pathological effects, it
Table 3 Statistically significant changesa in blood chemistry parameters 24 h and 90 days after a 90-day exposure of male and


















HCDb, c 21.9 - 35.0 0.20 - 1.08 138. 5- 149.2 3.22 - 4.47 99.9 - 109.2 2.55 - 2.97 62.10 - 73.54
24 h post exposure
0 23.7 0.48 142.8 4.13 102.3 2.68 66.15
0.05 24.6 0.38* 142.9 4.20 102.1 2.67 65.39
0.25 23.6 0.37* 143.9 4.25 103.0 2.69 67.02
5.0 22.4 0.41 144.2 4.52** 103.0 2.69 66.97
90 days post exposure
0 27.9 0.77 145.5 4.52 103.4 2.75 69.08
0.05 25.5* 0.68 145.7 4.59 103.2 2.77 68.42
0.25 24.4** 0.75 145.9 4.58 104.4 2.71 67.41
5.0 26.3 0.79 145.8** 4.73 104.5 2.74- 68.24
FEMALE
HCDb, c 25.0 - 41.7 0.18 - 0.57 137.8 - 147.8 2.73 - 3.90 100.6 - 110.3 2.53 - 2.99 63.62 - 79.36
24 h post exposure
0 30.4 0.32 143.5 3.43 102.0 2.75 72.27
0.05 27.7 0.31 144.8 3.95** 103.8 2.76 71.50
0.25 28.3 0.35 144.0 4.17** 103.4 2.80 72.87
5.0 27.3* 0.30 145.8 3.81* 105.3** 2.72 69.27*
90 days post exposure
0 28.8 0.72 143.5 3.40 101.7 2.78 77.11
0.05 31.9 0.60 146.4** 3.41 104.1 2.76 74.74
0.25 30.1 0.54* 144.9 3.21 101.9 2.72* 74.78
5.0 30.6 0.47** 145.1 3.54 104.0 2.74 72.29**
* p < 0.05, ** p < 0.01; statistical significant differences to controls
a No statistically significant changes were observed at any concentrations and time-points on glucose, urea, bilirubin, cholesterol, triglycerides, phospholipids, as-
partate aminotransferase (ASAT), alanine aminotransferase (ALAT), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT),
creatine kinase (CK), phosphorus, albumin and globulin
b HCD Historical control data, 95 % tolerance limits
c Changes statistically significant outside the HCD are in italic characters
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was thought to be of no toxicological significance and
related to the clearance process.
The changes in the biochemical parameters (Table 5,
Fig. 2) and cytokines levels (Table 6, Fig. 2) observed at
5.0 mg/m3 were of similar intensity as at 24-h post-
exposure. No change of the biochemical parameters was
observed at 0.05 and 0.25 mg/m3 except a persistent in-
crease of TNF-α levels in males and females exposed at
0.25 mg/m3 (x2.4 and x2.1, respectively) related to the
residual amount of black particles in the lungs.
Organs weights and macroscopic examination
5-day exposure with a 28-day recovery period
There were no macroscopic lesions that could be attrib-
uted to treatment with Graphistrength© C100. No change
was observed in lung weight at either sacrifice times (data
not shown). The absolute kidney weight was statistically
significantly reduced just after the 5-day exposure in males
exposed to 0.25 and 1.25 mg/m3 (1.71 and 1.77 g vs.
2.00 g in control, respectively, p < 0.01) as well as the
kidney to body weight ratio at 0.25 mg/m3 (0.56 % vs.
0.61 % in control, p < 0.05). However, in the absence of
histological correlates, effects in females and after the 28-
day recovery period, the kidney weight change was not
considered to be treatment-related. There were no further
effects on organ weights which were considered to be pos-
sibly related to treatment (data not shown).
90-day exposure with a 90-day recovery period
Black brown foci in the lung and black brown discolor-
ation of the bronchial lymph nodes were recorded in all
or most animals 24 h and 90 days after 90 days of expos-
ure to 5.0 mg/m3. No test item-related macroscopic
findings were observed in animals exposed to 0.05 and
0.25 mg/m3.
Twenty-hour hours post-exposure, absolute and
relative (to body weight) lung weights were increased
in males (+47 and +50 %, respectively) and females
(+45 and +50 %, respectively) exposed to 5.0 mg/m3
(Table 7). Lung weight (absolute and relative) were
still increased in males (+62 and +53 %, respectively)
and females (+45 and +36 %, respectively) exposed to
5.0 mg/m3 after 90 days of recovery (Table 7). All
other statistically significant changes in organ weights
were incidental and not considered to be treatment-
related (data not shown).
Table 4 Cell analysis in the BALF of male and female rats 24 h and 90 days after a 90-day exposure to Graphistrength© C100
Concentration (mg/m3) Total cell Count Viability Macrophages Eosinophils Lymphocytes Neutrophils Epithelial cells
106 % % % % %
MALE
24 h post exposure
0 1.74 84.40 93.9 0.0 4.4 1.5 0.1
0.05 1.62 84.65 91.8 0.0 5.1 3.1 0.0
0.25 2.24 89.00 64.8** 0.0 9.7* 25.2** 0.3
5.0 2.01 88.00 31.5** 0.0 12.8** 55.6** 0.1
90 days post exposure
0 1.80 90.10 96.5 0.0 2.1 1.2 0.2
0.05 2.21 91.35 96.9 0.0 1.9 0.9 0.3
0.25 2.85* 91.35 91.2 0.1 3.8 4.7 0.3
5.0 6.23** 89.86 44.6** 0.0 20.4** 39.8** 0.3
FEMALE
24 h post exposure
0 1.67 91.80 96.9 0.0 2.5 0.4 0.1
0.05 1.27 92.55 94.5 0.0 4.4 1.0 0.1
0.25 2.16 92.55 80.9** 0.0 4.1 15.0** 0.0
5.0 2.98** 95.50 34.7** 0.0 11.5** 53.8** 0.0
90 days post exposure
0 1.67 86.39 96.1 0.0 3.1 0.5 0.2
0.05 1.66 85.40 95.8 0.0 3.4 0.8 0.0
0.25 1.86 87.55 93.9 0.0 3.3 2.8 0.0
5.0 4.02** 88.80 46.7** 0.0 13.0** 40.1** 0.0
* p < 0.05, ** p < 0.01; statistical significant differences to controls
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Fig. 1 BALF parameters of male (a) and female (b) rats 24 h after a 90-day exposure to Graphistrength© C100. Changes are shown as x-fold
differences compared to controls using a logarithmic scaling. Abbreviations: ALP: alkaline phosphatase, GGT: γ-glutamyltransferase, LDH: lactate
dehydrogenase, IL-1β: interleukin 1β, TNF-α: Tumor Necrosis Factor α
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Fig. 2 BALF parameters of male (a) and female (b) rats 90 days after a 90-day exposure to Graphistrength© C100. Changes are shown as x-fold
differences compared to controls using a logarithmic scaling. Abbreviations: ALP: alkaline phosphatase, GGT: γ-glutamyltransferase, LDH: lactate
dehydrogenase, IL-1β: interleukin 1β, TNF-α: Tumor Necrosis Factor α
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Microscopic examination
5-day exposure with a 28-day recovery period
Findings observed in the lungs are summarized in
Additional file 1: Table S7 and typical lesions are
shown in Additional file 1: Figure S6. Twenty-four
hours post exposure, hypertrophy of the bronchial and
bronchiolar epithelial cells (Additional file 1: Figure S6
panel B) and an increased severity of the infiltration of
macrophages were noted in several animals exposed to
1.25 mg/m3. Black inclusions in the cytoplasm of the
infiltrated macrophages (Additional file 1: Figure S6 panel
C) were observed in a concentration-dependent manner
in all exposed animals confirming the observations done
in the BALF.
At the end of the 28-day recovery period, all these find-
ings were still present at a similar level, however, the inci-
dence and the severity of hypertrophy of the bronchial and
bronchiolar epithelial cells tended to be lower (only 4 ani-
mals affected, all with a minimal grade) (Additional file 1:
Figure S6 panel D). The other microscopic findings were
incidental lesions or within the range of normal back-
ground lesions for animals of this strain and age.
90-day exposure with a 90-day recovery period
Results of the microscopic examinations are presented
in Tables 8, 9 and 10 for lungs, tracheobronchial lymph
nodes and nasal cavity and larynx, respectively. Typical
lesions in lungs and tracheobronchial lymph nodes are
shown in Fig. 3.
Twenty-four hours post-exposure to Graphistrength©
C100, minimal to marked concentration-related depos-
ition of black particles were recorded in the lungs of all
exposed rats (Table 8, Fig. 3 panel a; for comparison a
picture of the lung of a control rat is displayed in Add-
itional file 1: Figure S6 panel A). After 90 days of recov-
ery, the mean severity decreased at 0.05 and 0.25 mg/
m3, indicating partial clearance of the black particles at
these two lower concentrations; however, at 5.0 mg/m3,
the mean severity score were overall similar indicating
incomplete clearance during this timeframe in these
lungs overloaded with Graphistrength© C100 particles.
At both sacrifice times, this deposition was associated
with minimal to moderate concentration-related infil-
tration of alveolar macrophages at 0.25 and 5.0 mg/m3
and with alveolar eosinophilic material (considered to
be the result of macrophages membrane cell rupture,
Fig. 3 panel b), minimal infiltration of neutrophils in the
alveoli (Fig. 3 panel c), and minimal to slight interstitial
inflammation (Fig. 3 panel a) at 5.0 mg/m3 only. Note-
worthy differences at the end of the 90-day recovery
period were the presence of minimal increased intersti-
tial collagen fibers (Fig. 3 panel d) in 3 males and 2
females exposed to 5.0 mg/m3 while the minimal bron-
chiolar cell hypertrophy/hyperplasia and increased lym-
phocytes in the bronchus associated lymphoid tissue
(BALT) occasionally observed just post-exposure were
not recorded anymore. Minimal deposition of black par-
ticles was also seen at the tracheal bifurcation in some
animals exposed at 5.0 mg/m3 at both sacrifice times.
Minimal to moderate dose-related deposition of black
particles in the tracheobronchial lymph nodes was the
histological correlate of the black discoloration recorded
at necropsy. This finding was recorded 24 h post-exposure
in animals exposed to 0.25 and 5.0 mg/m3 (Table 9, Fig. 3
panel e) and was associated with increased lymphocytes
within the cortex/paracortex and vacuolation of the endo-
thelial cells lining the high endothelial venules. After
90 days of recovery, the mean severity score of black par-
ticle deposition was similar at 0.25 mg/m3 and slightly in-
creased at 5.0 mg/m3 (Table 9, Fig. 3 panel f), consistent
with continuous drainage of black particles from the lungs
after the end of the treatment. In the meantime, the other
associated changes disappeared at 0.25 mg/m3 and their
intensities decreased at 5.0 mg/m3.
Table 5 Biochemistry parameters in the BALF of male and















24 h post exposure
0 0.16 196.8 37.6 5.9 92.7
0.05 0.21 168.6 38.8 6.7 84.2
0.25 0.36* 275.4 64.7 12.5** 115.4
5.0 1.05** 1306.2** 195.4** 19.5** 395.0**
90 days post exposure
0 0.26 225.7 76.4 5.6 115.4
0.05 0.27 174.8 78.2 6.3 79.8
0.25 0.42 237.2 108.5 9.5 102.3
5.0 1.18** 1353.2** 330.3** 16.1** 347.4**
FEMALE
24 h post exposure
0 0.17 163.6 34.9 5.1 78.8
0.05 0.18 163.0 28.8 6.6 91.2
0.25 0.30 312.7 63.4 12.5** 146.4
5.0 0.82** 1020.2** 144.1** 15.9** 292.6**
90 days post exposure
0 0.23 147.9 55.2 5.0 103.5
0.05 0.22 159.0 45.3 4.8 90.8
0.25 0.31 194.5 63.0 7.8 103.5
5.0 0.76** 566.2** 117.8** 15.8** 300.2**
* p < 0.05, ** p < 0.01; statistical significant differences to controls
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Table 6 Cytokines parameters in the BALF of male and female rats 24 h and 90 days after a 90-day exposure to Graphistrength© C100
Mean ± sd (pg/mL) # IL-1β IL-5 TNF-α IL-1 α
MALE
24 h post exposure
0 mg/m3 11.52 ± 6.43 0 ± 0.0 1.34 ± 0.60 3.38 ± 6.40
0.05 mg/m3 12.83 ± 9.11 0 ± 0.0 1.47 ± 0.84 11.31 ± 11.70
0.25 mg/m3 13.43 ± 5.96 0 ± 0.0 4.56 ± 1.55** 5.99 ± 6.82
5.0 mg/m3 10.60 ± 2.58 0 ± 0.0 8.17 ± 2.66** 0 ± 0.0
90 days post exposure
0 mg/m3 15.68 ± 5.65 2.30 ± 4.87 1.83 ± 0.75 6.46 ± 4.20
0.05 mg/m3 18.40 ± 3.69 7.12 ± 4.43* 2.21 ± 2.25 10.20 ± 8.39
0.25 mg/m3 21.38 ± 6.63* 12.38 ± 9.33** 4.46 ± 1.54** 9.82 ± 8.16
5.0 mg/m3 24.64 ± 7.28** 4.63 ± 6.38 9.03 ± 2.28** 21.74 ± 24.45*
FEMALE
24 h post exposure
0 mg/m3 7.74 ± 2.90 1.34 ± 1.78 0.77 ± 0.20 7.15 ± 9.35
0.05 mg/m3 6.31 ± 3.24 0.78 ± 1.27 0.80 ± 0.37 6.44 ± 10.70
0.25 mg/m3 13.48 ± 5.58 0.06 ± 0.18 6.53 ± 7.33** 11.94 ± 11.61
5.0 mg/m3 13.81 ± 7.47** 0.57 ± 1.81 7.68 ± 1.35** 13.16 ± 17.70
90 days post exposure
0 mg/m3 16.83 ± 4.57 13.41 ± 11.01 2.12 ± 0.85 9.94 ± 6.86
0.05 mg/m3 15.63 ± 4.22 8.00 ± 3.54 1.89 ± 0.66 9.52 ± 10.59
0.25 mg/m3 16.42 ± 3.66 4.98 ± 5.00 4.54 ± 1.33** 6.75 ± 8.24
5.0 mg/m3 24.57 ± 5.42** 1.46 ± 3.60 11.16 ± 4.91** 4.49 ± 6.54
* p < 0.05, ** p < 0.01; statistical significant differences to controls
# mean value higher than mean + 2sd of the corresponding control group are in italic characters
Table 7 Lung weights of male and female rats 24 h and 90 days after a 90-day exposure to Graphistrength© C100
Mean ± sd 0 mg/m3 0.05 mg/m3 0.25 mg/m3 5.0 mg/m3
MALE
24 h post exposure
Absolute weight (g) 1.50 ± 0.06 1.48 ± 0.14 1.63 ± 0.13 2.21 ± 0.29**
% body weight 0.38 ± 0.03 0.39 ± 0.02 0.41 ± 0.02 0.57 ± 0.05**
90 days post exposure
Absolute weight (g) 1.49 ± 0.08 1.58 ± 0.16 1.56 ± 0.07 2.42 ± 0.30**
% body weight 0.30 ± 0.02 0.32 ± 0.02 0.31 ± 0.03 0.46 ± 0.05**
FEMALE
24 h post exposure
Absolute weight (g) 1.19 ± 0.10 1.05 ± 0.07* 1.26 ± 0.09 1.73 ± 0.18**
% body weight 0.48 ± 0.04 0.46 ± 0.03 0.51 ± 0.04 0.72 ± 0.04**
90 days post exposure
Absolute weight (g) 1.18 ± 0.14 1.20 ± 0.09 1.27 ± 0.14 1.73 ± 0.12**
% body weight 0.38 ± 0.04 0.42 ± 0.03 0.44 ± 0.05** 0.64 ± 0.06**
*/**: Dunnett-test based on pooled variance significant <0.05 (*) or <0.01 (**)
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Cytoplasmic eosinophilic globules (inclusions) in the
respiratory and olfactory epithelial cells were observed
with increased incidence/severity at 5.0 mg/m3 in males
and females at both sacrifice time, albeit to lower magni-
tude after 90 days of recovery indicating partial revers-
ibility (Table 10). Such findings are frequently observed
Table 8 Microscopic findings in the lungs of male and female rats 24 h and 90 days after a 90-day exposure to Graphistrength© C100
Males Females
Target concentration (mg/m3) 0 0.05 0.25 5.0 0 0.05 0.25 5.0
Number examined 10/10 10/10 10/10 10/10 10/10 10/10 10/10 10/10
(24 h/90 days)
Black particle deposition
trace - -/10 - - - -/10 - -
minimal - 9/- -/10 - - 10/- 2/10 -
slight - - 10/- - - - 8/- -
moderate - - - -/2 - - - 4/3
marked - - - 10/8 - - - 6/7
Mean severitya - 0.9/0.5 2.0/1.0 4.0/3.8 - 1.0/0.5 1.8/1.0 3.6/3.7
Alveolar macrophages
minimal - - 8/10 -/1 - - 9/10 -
slight - - - -/3 - - - 1/8
moderate - - - 10/6 - - - 9/2
Mean severitya - 0.0 0.8/1.0 3.0/2.5 - - 0.9/1.0 2.9/2.2
Alveolar eosinophilic material
minimal - - - 6/8 - - - 4/4
slight - - - 2/2 - - - 4/5
moderate - - - 1/- - - - 1/-
Mean severitya - - - 1.3/1.2 - - - 1.5/1.4
Alveolar granulocyte infiltration
minimal - - - 10/8 - - - 10/7
Mean severitya - - - 1.0/0.8 - - - 1.0/0.7
Interstitial inflammation
minimal - - - -/1 - - - 4/5
slight - - - 10/9 - - - 6/5
Mean severitya - - - 2.0/1.9 - - - 1.6/1.5
Bronchiolar cell hypertrophy/hyperplasia
minimal - - - 10/- - - - 10/-
Mean severitya - - - 1.0/- - - - 1.0/-
Focal/multifocal collagen depositions, alveolar septa
minimal - - - - - - - -/2
slight - - - -/2 - - - -
Mean severitya - - - -/0.4 - - - -/0.2
Increased lymphocytes, BALTb
minimal - - - 2/- - - - 2/-
slight - - - 1/- - - - -
Mean severity - - - 0.4/- - - - 0.2/-
Histopathological findings were graded in severity using a five point system of minimal (grade 1), slight (grade 2), moderate (grade 3), marked (grade 4) or severe
(grade 5). An additional grading unit, trace (grade 0.5), was used to describe a trace amount of black particle deposition in the lungs
a: mean severity is ∑ number of animals x severity / number of examined organs in the group
bbronchus associated lymphoid tissue
- : no animal affected
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in inhalation studies [33] and are considered to be evi-
dences of irritation [34].
Twenty-four hours post exposure, minimal squamous
metaplasia was observed in the larynx in 2 males ex-
posed to 0.25 mg/m3 and 4 males and 5 females exposed
to 5.0 mg/m3. At the end of the 90-day recovery period,
minimal squamous metaplasia was still recorded in the
larynx of 1 male exposed to 5.0 mg/m3 (Table 10). This
finding, restricted to the ventral larynx at the base of the
epiglottis, is a common reaction to inhaled material and,
when of minimal severity, is considered to be a non-
adverse adaptive change [35].
No microscopic changes were observed in the respira-
tory tract of rats exposed to 0.05 mg/m3. All other find-
ings observed at 5.0 mg/m3 were those commonly seen
as spontaneous changes in the rat and bore no relation-
ship to the exposure to Graphistrength© C100. Specific-
ally, no histological lesions were observed in pleura
Table 9 Microscopic findings in the tracheobronchial lymph nodes of male and female rats 24 h and 90 days after a 90-day
exposure to Graphistrength© C100
Males Females
Target concentration (mg/m3) 0 0.05 0.25 5.0 0 0.05 0.25 5.0
Number examined 10/10 10/8 10/9 10/10 10/8 9/10 10/10 10/10
(24 h/90 days)
Black particle deposition
minimal - - 8/5 - - - 5/3 1
slight - - -/2 6/3 - - - 7/1
moderate - - - 4/7 - - - 1/9
Mean severitya - - 0.8/0.9 2.4/2.7 - - 0.5/0.3 1.8/2.9
Increased lymphocytes, cortex/paracortex
minimal - - 3/- 4/7 - - 1/- 3/6
slight - - - 3/2 - - - 7/-
moderate - - - 3/- - - - -
Mean severitya - - 0.3/- 1.9/1.1 - - 0.1/- 1.7/0.6
Endothelial vacuolation, high endothelial venule
minimal - - 1/- 1/2 - - - 2/5
slight - - 1/- 7/1 - - - 5/-
Mean severitya - - 0.3/- 1.5/0.4 - - - 1.2/0.5
Histopathological findings were graded in severity using a five point system of minimal (grade 1), slight (grade 2), moderate (grade 3), marked (grade 4) or severe
(grade 5)a: mean severity is ∑ number of animals x severity / number of examined organs in the group
a: mean severity is ∑ number of animals x severity / number of examined organs in the group - : no animal affected
Table 10 Microscopic findings in the nasal cavity and larynx of male and female rats 24 h and 90 days after a 90-day exposure to
Graphistrength© C100
Males Females
Target concentration (mg/m3) 0 0.05 0.25 5.0 0 0.05 0.25 5.0
Number examined 10/10 10/0 10/10 10/10 10/10 10/0 10/10 10/10
(24 h/90 days)
Nasal cavity epithelium, eosinophilic globules
minimal 4/2 - 2/3 2/6 -/3 - 3/2 1/4
slight -/1 - - 3/2 - - - 6/2
moderate - - - 5/2 - - - 2/3
Mean severitya 0.4/0.4 - 0.2/0.3 2.3/1.6 -/0.3 - 0.3/0.2 1.9/1.7
Larynx, squamous metaplasia
minimal - - 2/- 4/- - - - 5/1
Mean severitya - - 0.2/- 0.4/- - - - 0.5/0.1
Histopathological findings were graded in severity using a five point system of minimal (grade 1), slight (grade 2), moderate (grade 3), marked (grade 4) or severe
(grade 5)a: mean severity is ∑ number of animals x severity / number of examined organs in the group
a: mean severity is ∑ number of animals x severity / number of examined organs in the group - : no animal affected
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Fig. 3 Microscopic appearance of lungs around terminal bronchiole and tracheochonchial lymph nodes 24 h or 90 days after a 90-day exposure
to 5.0 mg/m3 of Graphistrength© C100. a End of exposure. Presence of black particles within the alveolar macrophages (blue arrow) and tissue
macrophages (red arrow). Note the interstitial inflammation around the alveolar duct with macrophages arranged as a small nodule-like structure
(black arrow), forming concentric layers around black particles. b End of exposure. Presence of black particles within alveolar macrophages (blue arrow)
or free within the alveolar lumen, admixed with the eosinophilic material (black arrow). c End of exposure. Presence of black particles within the
alveolar macrophages (blue arrow) and tissue macrophages (red arrow) around a blood vessel. Note the intact pleura (black arrow). d End of recovery.
Presence of interstitial collagen fibers protruding within the alveolar lumen (blue arrow) (e) End of exposure. Presence of black particles (blue arrow) in
tracheobronchial lymph node associated with increased lymphocytes in the cortex/paracortex. f End of recovery. Tracheobronchial lymph node with
large deposit of black particles (blue arrow). Original lens magnification: (a), (b), (c) and (d): 40-fold; (e): 6.3-fold; (f): 25-fold
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(Fig. 3, panel c) and olfactory bulb and no deposit of
MWCNT aggregate was observed in the liver, kidneys
and bone marrow and other organs of these exposed
animals.
Seminology and spermatid count
Twenty-four hours and 90 days post-exposure, there were
no adverse and/or treatment related effects on the sperm
counts, motility and morphology (data not shown).
Micronucleus test
No increase in the frequency of micronucleated poly-
chromatic erythrocytes (PCE) and no signs of medullar
toxicity were observed in male and female rats 24 h after
90 days of exposure to 0.05, 0.25 and 5.0 mg/m3 of
Graphistrength© C100 (Table 11). Statistically significant
increases in the frequency of PCEs with micronuclei
were observed in males and females treated with the
positive control CPA.
Comet assay
No increase in the tail intensity (mean of median), in ab-
sence and presence of hOGG1, was observed in isolated
lung, liver and kidney cells of the male rats 24 h after
90 days of exposure to 0.05, 0.25 and 5.0 mg/m3 of
Graphistrength© C100 (Table 12). Statistically significant
increases in percent of DNA in tail were observed in




These 5-day and 90-day inhalation toxicity and geno-
toxicity studies on Gaphistrength© C100 were performed
after a careful tuning of the conditions for the gener-
ation of a respirable aerosol which respect the physico-
chemical properties of the MWCNT and allow exposure
of all relevant regions of the respiratory tract (MMAD <
3 μm). The procedure that was considered to be most
appropriate for this type of agglomerated MWCNT con-
sisted of ball milling and aerosol generation from the
sieved material using an aerosol type generator (dust dis-
perser) that minimizes the physical stress to the test ma-
terial. This approach was subsequently refined by
milling the original Gaphistrength© C100 under an
argon atmosphere to minimize the surface oxidation. An
extensive set of physico-chemical investigations was per-
formed and there were generally no relevant modifica-
tions between the raw Graphistrength© C100 and the
aerosol generated from milled and sieved Graphis-
trength© C100. The few changes that occurred were
considered to be secondary to the reduction of the par-
ticle size and the sieving process. These changes were
minor and within acceptable limits considering the
procedure used for aerosol generation. In contrast, we
observed markedly elevated levels of oxygen surface con-
tent in aerosol samples from a previous 5-day inhalation
toxicity study with Graphistrength© C100 [16] (see the
1). This observation was accompanied by marked surface
damages (lace-like appearance) of the MWCNT noticed
by TEM which was not apparent by SEM. The principal
difference in preparation of the test material consisted in
the use of a rotating brush generator which may have
scratched the surface of the MWCNT. Surface proper-
ties [36, 37] and structural defects [38, 39] being an im-
portant factor governing biological effects of MWCNT,
the higher levels of the BALF toxicity markers and sever-
ity of the lung microscopic changes reported in this
study [16] than those observed in our 5-day study are
thought to be the consequence of the alteration of the
MWCNT by the use of a rotating brush generator.
In both the 5-day and 90-day exposure studies,
concentration-related increases of black inclusions
(regarded to be MWCNT) were observed in the cyto-
plasm of infiltrated macrophages, indicating an ad-
equate exposure of the lungs. After 5 days of exposure,
the principal findings were limited to the lungs and es-
pecially a minimal to slight hypertrophy of the bronchial
and bronchiolar epithelial cells and an infiltration of
macrophages at 1.25 mg/m3. Partial recovery was noted
after a 28-day treatment free period. These changes
were considered to be a normal physiological response
to insoluble particles overload and not adverse.
Twenty-four hours after 90 days of exposure to Gra-
phistrength© C100 and also after 90 days of recovery,
the signs of systemic effects were limited to an in-
crease in neutrophil counts and a concomitant de-
crease in lymphocyte counts in blood of rats exposed
to 5.0 mg/m3 but without change in the total WBC
counts. These effects, also observed in a 90-day inhalation
study with MWCNT NC 7000 from Nanocyl [40, 41],
were most probably secondary to the inflammatory re-
sponse observed in the lungs of the exposed animals.
The microscopic examinations of the heart and aorta,
the plasma cholesterol and measurement of the blood
pressure after 90 days of exposure did not suggest any
cardiovascular changes which could be associated with
accelerated progression of atherosclerosis as suggested
by Cao et al. [17] after 5 weekly i.t. instillations of Gra-
phistrength© C100 in wild type and atherosclerosis-
prone ApoE−/− transgenic mice. As well, the anemic and
procoagulant effects reported in Bmal1 (brain and
muscle ARNT-like protein-1) knockout (Bmal1−/−) mice
after 5 weekly oropharyngeal aspirations of Graphis-
trength© C100 [25] were not observed in the rats ex-
posed 90 days by inhalation. The microscopic
examination of olfactory bulb and brain sections of the
rats exposed to Graphistrength© C100 did not suggest
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that MWCNT crossed the blood-brain barrier and enter
into the olfactory bulb of the brain [42].
After 90 days of exposure to 5.0 mg/m3 of Graphis-
trength© C100, a black brown discoloration of the lung
and/or greenish foci were seen in most of the rats. This
was associated with an increase of around 50 % of the
lung weights. The pulmonary reaction to this overload
with insoluble particles was revealed by changes in the
cytological, biochemical and cytokine parameters of
BALF, slight at 0.25 and marked at 5.0 mg/m3. All the
changes (excepted for TNF-α) observed at 0.25 mg/m3
reversed after 90 days of recovery, whereas no clear
Table 11 Results of the micronucleus assay in the bone marrow of male and female rats 24 h after a 90-day exposure to
Graphistrength© C100
Test groups Concentration / dose level PCEs with micronuclei (%) Rangea PCE per 2000 erythrocytes
(n = 5/group) (mg/m3)
MALE
Air control 0 0.340 2 - 17 1099
Graphistrength© C100 0.05 0.440 5 - 11 1073
0.25 0.280 2 - 10 1094
5.00 0.210 3 - 8 1081
Positive controlb 20 0.833* 10 - 26 806
FEMALE
Vehicle 0 0.290 3 - 9 1155
Graphistrength© C100 0.05 0.210 1 - 8 1223
0.25 0.190 1 - 5 1147
5.00 0.220 2 - 9 1091
Positive controlb 20 0.750** 8 - 28 813
*/**: Non-parametric Mann-Whitney test significant <0.05 (*) or <0.01 (**)
aper 2000 PCEs per animal
bCPA, 20 mg/kg bw
Table 12 Results of the comet assay with and without hOGG1 in the lung, kidneys and liver of male rats 24 h after a 90-day
exposure to Graphistrength© C100
Test groups (n = 5/group) hOGG1 Air control Graphistrength© C100 (mg/m3) Positive controla
0 0.05 0.25 5.0
LUNG
% of DNA in tailb - 8.8 ± 5.5 3.4 ± 1.5* 8.2 ± 5.1 4.7 ± 3.7 48.7 ± 3.0**
+ 20.2 ± 5.2 16.7 ± 5.7 22.3 ± 11.8 17.9 ± 5.9 79.1 ± 7.9**
Relative ratio of ghost cellc - - 1.0 1.2 0.8 0.6**
+ - 2.1** 2.0** 1.3 1.1
KIDNEYS
% of DNA in tailb - 7.4 ± 4.4 7.5 ± 4.2 8.2 ± 4.2 9.7 ± 3.1 72.5 ± 5.8**
+ 22.8 ± 7.4 22.4 ± 7.3 23.4 ± 8.4 24.3 ± 8.0 74.0 ± 5.9**
Relative ratio of ghost cellc - - 1.6 0.9 1.5 2.8**
+ - 1.1 1.6* 1.7** 0.6*
LIVER
% of DNA in tailb - 3.8 ± 3.1 3.4 ± 1.6 1.8 ± 1.0 5.5 ± 2.9 71.2 ± 9.1**
+ 11.6 ± 6.4 7.5 ± 1.5 7.7 ± 1.1 9.6 ± 3.0 78.6 ± 3.7**
Relative ratio of ghost cellc - - 0.2 0.5 2.8** 4.9**
+ - 0.5* 0.2** 1.1 1.7**
*/**/***: Non-parametric Mann-Whitney test significant <0.05 (*), <0.01 (**)
aMMS
bMean of median ± sd
cMean value in treated groups/mean control value
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improvement was observed at 5.0 mg/m3. These changes
in BALF correlated with a concentration-related depos-
ition of black particle in the lungs, which decreased at
0.05 and 0.25 mg/m3 after 90 days of recovery. However,
at 5.0 mg/m3, the mean severity scores of black particle
deposition were overall similar at both time points, indi-
cating a significant overload of the lungs. The increase
of alveolar macrophages and the changes in the tracheo-
bronchial lymph nodes at 0.25 and 5.0 mg/m3 were con-
sistent with the drainage of the black particles from the
lungs [43] and a retention halftime of 375 days estimated
in rats exposed for 90 days to 6 mg/m3 of MWCNT
Baytubes [44]. In animals exposed to 5.0 mg/m3, slight
inflammatory changes were observed in the lungs at
both sacrifice times. The interstitial inflammation mainly
around the alveolar ducts at the bronchiole-alveolar
junction and the cell hypertrophy/hyperplasia in the
terminal and respiratory bronchioles observed just
post-exposure were most likely reactive changes to the
surrounding inflammatory process. After the 90-day
recovery, additional findings were the presence of min-
imal or slight focal collagen deposition within alveolar
septae in a few rats. No microscopic changes were ob-
served in pleura. The minimal squamous metaplasia in
the larynx observed 24 h post-exposure to 0.25 and
5.0 mg/m3 was fully reversible at 0.25 mg/m3 and per-
sisted in one rat at 5.0 mg/m3 90 days post exposure.
The presence of epithelial eosinophilic globules in the
nasal cavity at 5.0 mg/m3 was only partially reversible.
All these changes in the respiratory tract by exposure
to Graphistrength© C100 were qualitatively consistent
with those reported in previous 90-day inhalation tox-
icity studies in rats [40, 41, 44] with two other types of
thin and tangled MWCNT produced as large agglom-
erates like Graphistrength© C100. All the pulmonary
changes induced by Graphistrength© C100 were sig-
nificantly less severe than those induced in rats ex-
posed for 90 days to 1.0 and 5.0 mg/m3 of the long
needle-like MWCNT-7 [45], notably the induction of
inflammatory and fibrotic effects in the pleura which
were not observed in our study.
Pauluhn [43] concluded that a post-exposure period of
6 months (c.a. 0.5 t½) would be suitable to reveal any
appreciable reversibility in the lungs after MWCNT ex-
posure. However, fibrotic response was found to develop
and persist about one year after an inhalation exposure
(4 times/week for 3 weeks) of male C57BL/6 J mice to
5.0 mg/m3 of MWCNT-7 [46]. Therefore, the evolution
of the inflammatory reaction in the lungs of the rats ex-
posed to Graphistrength© C100 for 90 days is still under
evaluation over a 1-year recovery period.
The effects of Graphistrength© C100 on the lungs of
mice were reported by Tabet et al. [47] after a single i.t.
instillation as micrometric agglomerates suspended in
DMEM. The Balb/C mice were then monitored for up
to 6 months. BALF analysis showed a dose-dependent
increase in total cell count and a significant influx of
neutrophils and macrophages only 24 h post-instillation.
The MWCNT were internalized in macrophages be-
tween 1 day and 1 month after instillation. Histology of
the lungs 24 h after instillation showed the presence of
widespread micrometric MWCNT agglomerates, which
were mainly located in the bronchiolar lumen and alveo-
lar ducts. After one week, clusters of cells surrounding
visible MWCNT agglomerates were seen near the ter-
minal bronchioles, the alveolar ducts and alveoli in the
lungs. However, no modification in mRNA expression of
various genes implicated in oxidative stress (SOD-2 and
HO-1), inflammation (CXCL2, TNF-α) and fibrosis
(αcollagen-1 and αcollagen-3) was quantified in lung ho-
mogenates and no evidence of fibrosis was found
6 months post exposure. Ronzani et al. [48] have also
assessed the inflammation and airway remodeling in
BALF or lung tissue of mice induced by surfactant-
dispersed Graphistrength© C100, 24 h after a single
(6.25 μg/mouse) and 7 days after repeated (1.5, 6.25 and
25 μg/mouse once a week over 3 weeks) intranasal instil-
lation(s). MWCNT distributed all throughout the mouse
airways and were observed in alveolar macrophages, epi-
thelial cells, and in infiltrated neutrophils. Mice that re-
ceived a single administration of MWCNT showed
neutrophils infiltrate and greater concentrations of TNF-
α, keratinocyte-derived chemokine (KC) and IL-17 in
BALF when compared to controls. After repeated Gra-
phistrength© C100 administrations, increases in macro-
phage number, KC and tumor growth factor (TGF)-β1
levels in BALF, and collagen deposition and mucus
hyperplasia in lung tissue were observed. Cao et al. [17]
exposed female wild-type C57BL/6 N Tac mice to total
doses of 32 and/or 128 μg Graphistrength© C100/mouse
administered by i.t. instillation once a week over 5 weeks.
Pulmonary inflammation was demonstrated one and/or
28 days after the last exposure by increased influx of
neutrophils and higher levels of cytokines (IL1β, IL6,
IL12, G-CSF, KC, CCL2, MIP1β, CCL5 and TNF) in
BALF, and increased levels of 8-isoprostanes in lung tis-
sue. Even if there are significant methodological differ-
ences (rat vs. mice, inhalation vs. i.t., 90-day exposure vs.
single or short-term administrations), consistently these
studies tend to show the same inflammatory reaction in
lungs to insoluble particles.
Genotoxicity studies
This subchronic inhalation toxicity study gave us the op-
portunity to evaluate the genotoxic potential of Graphis-
trength© C100 in in vivo studies as recommended by the
REACH guidance [49] when the set of the available gen-
otoxicity data doesn’t allow a definitive conclusion. The
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results of in vitro studies are conflicting. Graphis-
trength© C100 was negative in a battery of standard in
vitro genotoxicity assays [50] performed according to the
current OECD test guidelines no. 471 [51], 476 [52] and
473 [53] to assess the potential induction of gene muta-
tions in bacteria (Ames test) and mouse lymphoma cells,
and chromosomal aberrations in human lymphocytes, re-
spectively. Using nonstandard protocols, Kermanizadeh et
al. [18, 19] showed that exposure of human hepatoblas-
toma C3A and HK-2 cells at sub-lethal concentrations of
Graphistrength© C100 resulted in weak DNA damage in
the FPG-modified Comet assay. Conversely, Jackson et al.
[20] did not observe an increase of the level of DNA
strand breaks in the comet assay with FE1-Muta© Mouse
lung epithelial cell cultures exposed to Graphistrength©
C100, even if the product was able to generate ROS and
the highest tested concentration induced a decrease of the
cell proliferation.
In the EU Nanogenotox Joint Action [21], Graphis-
trength© C100 was reported to induce a weak increase
(≤2-fold compared to negative control) in the micronu-
cleated binucleated cell (MNBC) frequency in a primary
culture of human lymphocytes [22, 23], in adenocarci-
nomic human alveolar basal epithelial A549 and bron-
chial epithelial BEAS 2B cell lines [23], but not in the
bronchial epithelial 16 HBE and epithelial colorectal
adenocarcinoma Caco-2 cell lines [23]. Graphistrength©
C100 was also tested in the in vitro comet assay using
BEAS 2B, 16 HBE, A549 and Caco-2 cell lines [23]. In
BEAS 2B and Caco-2 cells, Graphistrength© C100 was
studied using the FpG-modified comet assay. The comet
assay was negative for all the cell lines with or without
FpG.
The results of the in vivo genotoxicity studies pub-
lished on Graphistrength© C100 are scarce and also not
conclusive. Cao et al. [17] reported a small increase (<2-
fold) of the level of DNA strand breaks, without effects
on the level of FPG sensitive sites, in lung tissue of dysli-
pemic C57BL/6 N-Apoe tm1 (ApoE-/-) mice exposed to
Graphistrength© C100 by i.t. instillation once a week for
5 weeks at total dose of 128 μg/mouse. This effect was
associated with a lung inflammation as demonstrated by
an influx of neutrophils in BALF. A 6-fold increase of
the mRNA expression of the DNA repair oxoguanine
DNA glycosylase 1 (Ogg1) enzyme was also observed in
lungs of the same exposed animals. The authors have sug-
gested, according to Risom et al. [54, 55], that after re-
peated exposures to Graphistrength© C100, up-regulation
of DNA repair counteracts the increased rate of 8-oxodG
formation leaving the steady state level of 8-oxodG in
DNA unchanged, whereas oxidative DNA damage could
be induced after a short-term exposure. However, this hy-
pothesis was not supported by the results of the FPG-
modified comet assay performed in the frame of the
Nanogenotox Joint Action [24]. Three to six hours after 3
daily i.t. instillations up to 320 μg/rat/day of Graphis-
trength© C100 to Wistar rats, no statistically significant in-
crease in the percentage of tail DNA was noticed in the
lung cells with and without FPG enzyme. According to
Pant et al. [56] a 2- to 10-fold variation of the background
levels of DNA damage is not unusual in the comet assay,
therefore, it is difficult to ascribe the 2-fold increase re-
ported by Cao et al. [17] to Graphistrength© C100 expos-
ure. In our study, 24 h after a 90-day inhalation exposure
with Graphistrength© C100, even in the presence of a clear
inflammatory reaction in the lungs, no primary and
hOGG1-sensitive oxidative DNA damage was detected by
the comet assay, either in the lung cells directly in contact
with the MWCNT or systemically in the liver and kidney
cells and no micronucleus induction was observed in the
bone marrow cells.
The genotoxic effects of MWCNT may result from
primary or secondary mechanisms [57]. Primary geno-
toxicity refers to the elicitation of genetic damage in the
absence of inflammation, either by a direct interaction
with genomic DNA or associated components that de-
termine its integrity, or indirectly through the enhanced
production of ROS by cellular constituents in response
to their interaction with particles or through the deple-
tion of antioxidants within the cell which can lead to the
induction of oxidative DNA damage [58]. Secondary
genotoxicity could be driven by inflammatory cells such
as macrophages and polymorphonuclear neutrophilic
leukocytes and in situations of chronic inflammation this
can lead to persistent oxidative stress and repeated DNA
insults [58]. Exposure to some MWCNT has been asso-
ciated with depletion of antioxidants, increased intracel-
lular production of ROS and pro-inflammatory signaling
in cultured cells [59]. In the case of Graphistrength©
C100 there is no clear evidence of ROS production. An
increase was observed in human hepatoblastoma C3A
cells [18], but not in human renal [19] or FE1-Muta©
Mouse lung epithelial [20] cells. After i.t. instillation(s)
of Graphistrength© C100 in the lung of mice, Tabet et
al. [47] did not see a modification in mRNA expression
of genes implicated in oxidative stress, whereas Cao et
al. [17] reported an increased expression of Hmox1.
Even if the ROS formation was not specifically evaluated
in our study, the lung inflammation, macrophage phago-
cytosis, TNF-α secretion in BALF and elevated numbers
of neutrophils in blood observed at 5.0 mg/m3 are indi-
cations of an oxidative stress. The negative comet result
in the lung cells exposed to Graphistrength© C100 could
be related to the ROS scavenger capability of carbon
nanotubes [60], which might limit the effects of the oxi-
dative stress, and could also limit the DNA damage. Fur-
thermore, the apparent absence of translocation of
Graphistrength© C100 from the lungs to the other
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organs could explain the lack of genotoxic effects in the
liver, kidney and bone marrow cells.
Therefore, the lack of in vivo genotoxicity of Graphis-
trength© C100 MWCNT indicates a toxicological profile
significantly different compared to the genotoxic long
needle-like MWCNT-7 [11, 61], classified by IARC [14] as
possibly carcinogenic to humans (Group 2B) and to some
other genotoxic thin and tangled MWCNT [62–64], even
if in these later cases, a role of residual cobalt catalyst,
which is a known genotoxin [65], could not be excluded.
Conclusion
Five-day and 90-day rat inhalation toxicity studies were
performed with MWCNT Graphistrength© C100. The
milling procedure and the dust disperser used as solid
aerosol generator produced an aerosol which retained
the physico-chemical integrity of the original product in
the test aerosols. This contrasts with a previous inhal-
ation study with the same MWCNT product [16], using
an aerosol produced with a rotating brush generator in
which the structure of the MWCNT was affected. In the
present study, principal health findings were limited to
the lungs. The infiltration of phagocytizing macrophages
is thought to be a trigger and results from the host reac-
tion towards foreign bodies [66]. The inflammation may
also deteriorate the alveolar barrier function which
increased particle translocation to the draining lymph
nodes of the lung [44]. Bronchial and alveolar epithelia
were influenced secondarily. During an inhalation study,
at a certain time point, a lung burden is reached that ex-
ceeds the macrophage clearance capacity and results in
overload effects [66]. It seems to be the case at 5.0 mg/m3,
as Graphistrength© C100 deposition persisted in the lung
without apparent signs of decrease after a 90-day
treatment-free period, whereas at 0.25 mg/m3 clear signs
of clearance and recovery were observed. Prolonged TNF-
α release in BALF was observed at 0.25 and 5.0 mg/m3
which was associated only at 5.0 mg/m3 with an increased
collagen staining like that reported by Pauluhn [44] with
MWCNT Baytubes. The lack of genotoxicity in the lung
cells and microscopic change in the pleura indicated a
lung reaction to Graphistrength© C100 exposure quite dif-
ferent than that of the asbestos-like MWCNT-7 and could
be related to the absence of internalization of Graphis-
trength© C100 by the alveolar or mesothelial cells as
shown by Tabet et al. [67] with human epithelial A549
and mesothelial MeT5A cell lines cultures. Overall, these
effects are consistent with a normal physiological and not
adverse response to the overload of the lung with insoluble
particles [44]. Considering the limited and reversible
effects on the BALF parameters, the lack of patho-
logical changes in the lungs and the clearance of the
Graphistrength© C100 observed at 0.25 mg/m3, this
concentration can be considered as a No-observed
Adverse Effect Concentration (NOAEC). In spite of the
inflammatory response, neither primary nor oxidative
DNA damages were observed locally in lung. The lack
of DNA damage or chromosomal aberration remotely
in the liver, kidneys and bone marrow was most prob-
ably related to the lack of bioavailability via a systemic
translocation of the MWCNT from the lungs. There-
fore, Graphistrength© C100 appears of low concern in
term of local and systemic genotoxicity and a NOAEC
of 0.25 mg/m3 (0.28 mg/m3 as actual concentration)
was established for the repeated-dose toxicity.
Methods
General
The present studies were conducted according to the
OECD Principles of Good Laboratory Practice [68] and
the OECD test guidelines no. 413 [29], 474 [69] and 489
[70]. The design of the 90-day inhalation toxicity study
was developed taken into account the OECD recom-
mendations [30] for the revision of the tests guidelines
applicable to the inhalation toxicity testing of nanoma-
terials. A graphical representation of the design of the 5-
and 90-day studies is presented in Fig. 4. The studies
were performed in an AAALAC-accredited laboratory in
accordance with the Swiss Animal Protection Law.
Test materials
Graphistrength© C100, are exclusively produced by
Arkema France, Colombes, France. SEM and TEM im-
ages (Fig. 5) show that Graphistrength© C100 is made of
tightly bound agglomerates constituted with entangled
MWCNT. These agglomerates can be spherical, ovoid or
irregular shaped and have a granulometry centred on
400 μm, with fragments of pellets of less than 15 μm repre-
senting a volume of under 0.23 % [27]. The MWCNT of
Graphistrength© C100 are synthesized at high temperature
using a fluidized bed with ethylene as a carbon feedstock
and iron oxide (Fe2O3, ≤5 %, [1309-37-1]) on alumina
(Al2O3, ≤7 %, [1344-28-1]) as catalytic source. Batches nos.
8287 and 110329-018 of Graphistrength© C100 were used
for the 5-day and the 90-day exposure studies, respectively.
Positive control substances for the genotoxicity assays
were selected as recommended by the OECD test guide-
lines [69, 70]. Cyclophosphamide monohydrate (CPA,
batch A0302605, purity 97 %) from Fisher Scientific
GmbH for the micronucleus assay and methyl methane-
sulfonate (MMS, batch MKBL6789V, purity 99.9 %) from
Sigma-Aldrich for the comet assay.
Physico-chemical characterisations
The original Graphistrength© C100 batches and samples
taken at different steps of our aerosol generation process
during the method development (see the additional file 1)
were analyzed by SEM (ZEISS LEO 1530 VP Scanning
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Electron Microscope, LEO Elektronenmikroskopie GmbH,
Oberkochen, Germany equipped with an X-rays analyzer
Oxford type “Energy 200”) for the morphology of the
particles, by TEM (Philips-FEI CM 200 transmission
electron microscope, FEI, Hillsboro, Oregon, USA
working under electron beam accelerating voltages
from 20 kV to 200 kV and with a point-to-point reso-
lution of 0.27 nm) for the walls number, diameters,
length size and ends of the nanotubes, by laser method
for the particle size, by porosimetry with mercury in-
trusion for the apparent density, by BET method for
specific area (surface to volume ratio was calculated),
by calcination for ash content and the elementary or-
ganic analysis, by XPS for the chemical surface analysis
and by lithium tetraborate fusion method for metal
content. Further descriptions of the methods are in-
cluded in Additional file 1: Table S3.
As reported in the additional file, the effect of the mi-
cronisation and aerosolisation methods used for these 5-
day and 90-day exposure studies on the integrity and the
physico-chemical properties of Graphistrength© C100
was carefully examined during the method development.
It was also compared to the effect of a brush dust gener-
ator as used by Ma-Hock et al. [16] during another 5-
day inhalation toxicity study with Graphistrength© C100
(see the additional file 1).
Aerosol generation
Graphistrength© C100 was ground in a ceramic ball mill
for 20 h under air (5-day study) or 12 h under an argon
atmosphere to reduce oxidation (90-day study) and the
ground test material was sieved before the aerosol gener-
ation (see the additional file 1 for details).
The highest aerosol concentrations used for the 5-day
and 90-day exposure studies (1.25 and 5.0 mg/m3, re-
spectively) were generated from the milled and sieved
Graphistrength© C100 using a SAG 410 Solid Aerosol
Generator (Topas GmbH, Dresden, Germany) connected
to a micronizing jet mill (CR Equipement SA, Coppet,
Switzerland) and a cyclone and two elutriators (GlasKeller,
Basel, Switzerland) thereafter. The effect of the milling
duration on the structure (by TEM) and oxidation (by
XPS) of the MWCNT was evaluated in a pilot study as re-
ported in the additional file 1. The aerosols generated were
then discharged into the exposure chamber through a
63Ni charge neutralizer. The generated test aerosols were
diluted as necessary with compressed air to achieve the
concentrations required for the 5-day and 90-day inhal-
ation exposures. The aerosol concentrations for the low
and intermediate groups were achieved by serial dilution
with compressed, filtered, dry air of the higher aerosol
concentrations (mid and high concentrations, respectively)
using a TD190 H and TD190 M air vacuum device (Air-
Vac Engineering, Seymour, USA). The aerosol was dis-
charged constantly through the exposure system and
exhausted using a tubing/filter system. The exposure sys-
tem ensured a uniform distribution and provided a con-
stant flow of test material to each exposure tube. The flow
of air at each tube was between 0.73 to 1.0 L/min, which
was sufficient to minimize re-breathing of the test aerosol
as it was more than twice the respiratory minute volume
of a rat.
Fig. 4 Graphical representation of the design of the 5-day exposure/28-day recovery and 90-day exposure/90-day recovery studies. Abbreviations:
balf: bronchoalveolar lavage fluid; bp: blood pressure; cbf: clinical signs, body weight and food consumption; gt: genotoxicity tests (comet and mi-
cronucleus assays); hcu: hematology, blood chemistry and urinalysis; fob: functional observation battery; pa: pathology (organ weight, macroscopic
and microscopic observations); op: ophthalmology; sp: sperm analysis; vs: vaginal smears
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Fig. 5 Electron microscopic images of Graphistrength© C100. SEM of the commercial Graphistrength© C100. (a) Magnification: 22 fold. (b) Magnification:
120 fold. (c) Magnification: 10’000 fold
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Animals and husbandry
Healthy male and female Rats, RccHan©: WIST(SPF)
were supplied by Harlan Laboratories, B.V. (5961 NM
Horst, The Netherlands). After an acclimatization period
of at least 7 days, the animals were 11 and 8 weeks old
at the start of 5-day and 90-day exposures, respectively.
On the first day of the 5-day and 90-day exposures, the
body weights ranged from 291 to 347 g and 243 to 296 g for
males and from 176 to 214 g and 135 to 228 g for females,
respectively. The rats were randomly allocated by sex to the
control and the test groups in groups of maximally five in
Makrolon type-4 cages with wire mesh tops and sterilized
standard softwood bedding (“Lignocel” J. Rettenmaier &
Söhne GmbH & Co. KG, 73494 Rosenberg, Germany) in-
cluding paper enrichment (Enviro-dri from Lillico, Biotech-
nology, Surrey, UK). The animal room was air-conditioned
with 10-15 air changes/h, a 12 h light-12 h dark cycle, the
temperature ranging from 20 to 24 °C with relative hu-
midity ranging from 30 to 70 %. Except during expos-
ure, pelleted standard Harlan Teklad 2914C rodent
maintenance diet (Provimi Kliba AG, 4303 Kaiseraugst,
Switzerland) and water were provided ad libitum.
Animal exposure
Groups of 20 male or 10 female rats or 35 male and 35 fe-
male rats were exposed nose-only 6 h per day for 5 days
or 5 days per week for 90 days, respectively. Target con-
centrations were 0.05, 0.25 and 1.25 mg/m3 air and 0.05,
0.25 and 5.0 mg/m3 air of Graphistrength© C100 as low,
mid and high concentrations for the 5-day and 90-day in-
halation exposures, respectively. The choice of the con-
centrations for the 5-day exposure study was based on
published evidence on other MWCNT [40, 44]. Consider-
ing the limited effects observed in the 5-day range-finding
study, the same low and mid concentrations were used for
the 90-day exposure study and the high concentration was
increased up to the top concentrations tested in previous
90-day exposure studies [40, 44].
Animals of control groups (0 mg/m3) were exposed to
compressed air under the same conditions as animals ex-
posed to Graphistrength© C100. During nose-only inhal-
ation exposure, rats have a breathing pattern that results in
a more realistic internal exposure than a single high dose in
i.t. instillation and oropharyngeal aspiration or possible add-
itional oral exposure in whole-body exposure chambers. In-
halation exposure was performed using a flow-past system.
The animals were confined separately in restraint tubes
which were positioned radially around the flow-past, nose-
only exposure chamber as described by Cannon et al. [71].
As positive control groups for the genotoxicity assays,
5 males and 5 females were treated once by oral gavage
with 20 mg/kg bw cyclophosphamide (CPA) approxi-
mately 24 h before tissue sampling for the micronucleus
assay, and 5 males were treated by oral gavage with
methyl methane sulfonate (MMS) two times with 100 mg/
kg bw and then once with 70 mg/kg at approximately 24 h
intervals for the comet assay.
Monitoring and characterization of the test aerosol
The oxygen concentration, relative humidity and
temperature in the exposure device were measured con-
tinuously during each exposure using a calibrated device.
The nominal concentration was determined for the high
concentrations by weighing the generator reservoir con-
taining the test material before and after exposure and
dividing the used amount by the total air-flow volume.
These data were used to monitor the performance of the
generation system. During the 5-day and 90-day expo-
sures, gravimetric determinations of the aerosol concen-
trations were respectively performed once and 4 to 7
times daily for high concentrations and twice and 1 to 3
times daily for the low and mid concentrations using
Millipore® durapore filters, type HVLP, loaded in a
47 mm in-line stainless steel filter sampling device. The
sampling flow rates were respectively 3 to 4 and 1 L/min
per exposure port. For the low concentration of the 90-
day exposure study, filters were taken at the inlet pipe
with airflow of 3 to 4 L/min. The same device was used
to collect aerosol samples for TEM analysis.
For both exposure periods, the cumulative particle size
distribution of the test aerosol was determined using
Mercer cascade impactors (In-Tox Products, Moriarty,
USA). The test aerosol was impacted at each stage (cov-
ered with grease) and the particle size distribution of the
test material in the generated aerosol was measured by
gravimetric analysis of the test material deposited on
each stage of the cascade impactor.
During the 5-day exposure, measurements were per-
formed twice for the low and high concentrations and
once for the mid concentration using an impactor
Model 200 at a sampling rate of 9 L/min in order to col-
lect sufficient material for this short study period.
During the 90-day exposure, measurements were per-
formed at least once per week for the high concentration
and five times for the mid concentrations using a stand-
ard impactor Model 02-005 at a sampling rate of 1 L/
min, matching the air flow rate at the animal port to
avoid a possible imbalance of the aerosol flow within the
exposure chamber. Accordingly, impactor samples for
the mid concentration of the 90-day exposure were col-
lected over several days. No samples were collected for
the low concentration of the 90-day exposure as the
aerosol concentration was too low to obtain reliable re-
sults with an air flow rate of 1 L/min.
The mass median aerodynamic diameter (MMAD)
and the geometric standard deviation (GSD) were calcu-
lated on the basis of the results from the impactors,
using Microsoft Excel® software (Microsoft Corporation,
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USA). In addition, during the 90-day inhalation expos-
ure, the aerosol was analyzed once per week with a Wide
Range Particle Spectrometer© (WRPS, Model 1000XP,
MSP Corporation, Shoreview, USA) in the size range of
5 nm to 10 μm to determine the count median aero-
dynamic diameter (CMAD). The sampling airflow rate
was approximately 1 L/min.
Ante mortem observations
Cage-side clinical observations were recorded twice daily
before and after exposures. During the 90-day study, a
careful clinical examination of each animal was per-
formed once weekly in a standard arena. Food consump-
tions and body weights were recorded twice during the
5-day exposure and weekly during the 28-day recovery
and the 90-day exposure and 90-day recovery periods.
Functional observation battery, locomotor activity, grip
strength, landing foot splay, body temperature and oph-
thalmoscopic investigations were recorded during the
last week of the 90-day exposure period. In animals
fasted in metabolism cages for approximately 18 h,
hematology, blood chemistry and urinalysis (parameters
as per OECD test guideline no. 413 [29] and listed in Ta-
bles 2 and 3) were performed during the last week of the
90-day exposure. Hematology and blood chemistry were
repeated during the last week of the 90-day recovery
period. Tail cuff blood pressure was measured during
acclimatization and during the last week of the 90-day
exposure period. Vaginal smears for estrous cycle evalu-
ation were taken for 14 days from all females during
treatment weeks 11 and 12.
Post mortem observations
Twenty-four hours and 28 days after the 5-day exposure,
5 rats/sex/group were anaesthetized by i.p. injection of
pentobarbitone and killed by exsanguination for histo-
logical examinations and another 5 males/group served
for BALF investigations on both occasions. Twenty-four
hours and 90 days after the 90-day exposure, 10 rats/
sex/groups were sacrificed for organ weights, and
macroscopic, histological and BALF examinations.
Bronchoalveolar lavage fluid analysis
For broncho-alveolar lavage sampling, the complete
lungs (5-day study) or the left lobes of the lungs (90-day
study) were washed six times with physiological saline
(4.0 ml for the complete lungs or 1 x 2.5 mL + 5 x
1.5 mL for the left lobes) at room temperature by slow
instillation and withdrawal of fluid. The lavage fluid of
animals from the positive control group for the comet
assay was discarded. After washing, the left lung lobes
were preserved in mincing solution at 5 ± 3 °C for the
comet assay. The lavage fluids from the first (5-day
study) or the first two lavages (90-day study) were
collected in a centrifugation tube on ice. The recovered
volume from this wash was recorded. Approximately
0.75 or 1 mL of the fluid was placed into a second tube
containing 37.5 or 50 μL of 20 % BSA in PBS, respect-
ively. Both tubes were centrifuged at approximately
300 g for 10 min between 2 and 8 ° C. Thereafter, the
supernatant (without BSA) was taken in one tube and
immediately set on ice and stored at 2-8 ° C until ana-
lysis. The first aliquot (without BSA) was used for the
determination of the enzymatic activity of lactate de-
hydrogenase (LDH), alkaline phosphatase (ALP), and γ-
glutamyltransferase (GGT) as well as for the determin-
ation of total protein and/or phospholipids (storage at
2-8 ° C until analysis). The second aliquot from the 90-
day exposed and 90-day recovery animals was split into
three tubes, two of them containing approximately
0.1 mL each, the third one containing 0.3 mL and were
analyzed for contents of natural immunity mediator cy-
tokines (TNF-α, IL-1α and IL-1β) and adaptive immun-
ity mediator cytokines (IL-5). IL-5, IL-1-β and TNF-α
were analyzed using the Proinflammatory Panel 1 (rat)
Kit V-PlexTM from MSD. IL-α was analyzed using the
MSD® Multi-Spot Assay System, Rat Demonstration 7-
Plex Ultra-sensitive Kit.
The lavage fluid from the four further lavages was
pooled separately for each animal in a centrifugation
tube, and centrifuged at approximately 300 g for 10 min
between 2 and 8 °C. The supernatant was discarded.
The cell pellets were each suspended with physiological
saline and pooled with the suspended cell pellet from
the first two lavages. The total volume was gently
shaken for mixing. Aliquots of the cell suspension were
taken for total cell count, cell viability and differential
cell counting. A total cell count was performed by dilut-
ing an aliquot of the cell suspension in Türk’s stain
(Diagnostik Merck No. 9277, Merck AG, Darmstadt,
Germany). An aliquot of this mixture was introduced
into a hemocytometer chamber, and the cells were
counted (at least 1 mm3). A differential cell count was
performed. According to the results of the total cell
count, an aliquot of cell suspension was diluted with
physiological saline solution to give an end concentra-
tion of at least 106 cells/ml. From this suspension a
smear was prepared using a Cytocentrifuge (Shandon,
Instrument Gesellschaft AG, Switzerland) and stained
with Diff-Quick (Baxter Dade, Switzerland). At least
500 cells per smear were counted by light microscopy.
The number of each cell type (macrophages, neutro-
phils, lymphocytes, eosinophils, epithelial cells, and
other cells) was counted.
Macroscopic and organ weight examinations at necropsy
All animals were weighed at necropsy and descriptions
of all macroscopic abnormalities were recorded. The
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weights of adrenal glands, heart including auricles,
kidneys, liver, lungs, and spleen were determined in all
animals exposed for 5 days and 90 days (including re-
covery animals). In addition, weights of brain, epididy-
mis, ovaries, testes, thymus and uterus were recorded in
all animals exposed for 90 days (including recovery ani-
mals). The organ to terminal body weight ratios was
calculated.
Histopathology
Almost all organs were collected from all rats exposed for
5-day (including recovery animals). All gross lesions, all
organs as per OECD test guideline no. 413 [29], olfactory
bulb and pleura were collected from all rats exposed for
90 days (including recovery animals). Lung lobes were
instilled via trachea with neutral phosphate buffered 4 %
formaldehyde solution at approximately 30 cm H2O pres-
sure. The organs were fixed in formalin (excepted testes
fixed in modified Davidson’s solution), processed, embed-
ded and cut at an approximate thickness of 2 - 4 μm and
stained with hematoxylin and eosin.
For the 5-day exposure study, all gross lesions, heart
including auricles, kidneys, larynx, liver, spleen, medias-
tinal lymph nodes, nasal cavity, nasopharyngeal duct and
pharynx, spleen and trachea (adjacent to larynx and car-
ina and bifurcation) of the main and recovery rats from
the control and 1.25 mg/m3 groups were examined
microscopically. Lungs from all main and recovery rats
from all groups were examined.
For the 90-day exposure study, the microscopic exam-
ination of the respiratory tract and associated lymph
nodes was performed on all control and exposed animals
at both sacrifice periods (except the nasal cavity and lar-
ynx of the recovery rats exposed to 0.05 mg/m3). The
other organs, as per OECD test guideline no. 413 [29],
were examined for the control and 5.0 mg/m3 groups
rats sacrificed 24 h post-exposure (this microscopic
examination was not performed on the 90-day recovery
rats as no microscopic changes was observed in the 24-h
sacrificed rats).
A part of left lobe of lungs (also used for BALF), a
caudal part of kidney and the middle lobe of liver of
male rats exposed for 90 days were preserved for the
comet assay.
Semiology and spermatid count
Sperm motility, spermatid count in testis and sperm
count in cauda epididymis were performed on all males
exposed for 90 days and sacrificed 24 h and 90 days post
exposure (expect the sperm count in recovery males ex-
posed to 0.05 and 0.25 mg/m3). Sperm morphology was
analyzed on all males at the 24-h post exposure sacrifice
and on control and 5.0 mg/m3 exposed males after the
90-day recovery period.
Micronucleus test
The 5 last male and female rats (in the numbering order)
out of 10 of sacrificed 24 h after the 90-day exposure were
used for the micronucleus assay. The femora were re-
moved, the epiphyses cut off and the marrow was flushed
out with fetal calf serum, using a syringe (3 mL per femur).
The nucleated cells were separated from the erythrocytes
using the method of Romagna [72]. Briefly, the cell suspen-
sions were passed through a column consisting of α-
Cellulose (Sigma) and Cellulose (Sigmacell type 50) (1:1
mixture). The columns were then washed with Hank΄s
buffered saline. The cell suspensions were centrifuged at
1500 rpm (390 × g) for 10 min and the supernatant was
discarded. The pellet was suspended in a small drop of fetal
calf serum and spread on slides. The smears were air-dried,
fixed in methanol. The slides were stained with May-
Grünwald/Giemsa. For staining, the slides were first incu-
bated one minute in a 5 % May-Grünwald solution
followed by one minute in a 1:1 mixture of May-Grünwald/
phosphate buffer (pH 7.4). After 20 min in 14 % Giemsa so-
lution the slides were washed twice in phosphate buffer
and 10 s in deionized water. Cover slips were mounted
with EUKITT (Kindler, 79110 Freiburg, Germany). At
least one slide was made from each bone marrow sam-
ple. The slides were coded using a computer generated
coding list. Evaluation of the slides was performed using
NIKON microscopes with 100x oil immersion objec-
tives. Six thousand polychromatic erythrocytes (PCE)
were analyzed per animal for micronuclei.
The test is considered to be positive if there is either a
dose-related increase in the number of micronucleated
polychromatic erythrocytes or a statistically significant
positive response for at least one of the test points. In the
absence of a dose-related increase in the number of micro-
nucleated polychromatic erythrocytes or a statistically sig-
nificant positive response at any of the test points the
substance is considered non-genotoxic in this system. To
describe a cytotoxic effect the ratio between polychro-
matic and normochromatic erythrocytes was determined
in the same sample and expressed in polychromatic eryth-
rocytes per 2000 erythrocytes.
Comet assay
As suggested by the OECD test guideline no. 489 [70],
when there was no difference in toxicity between males
and females, the comet assay could be performed in either
sex. The 5 first male rats (in the numbering order) out of
10 sacrificed 24 h after the 90-day exposure were assigned
for the comet assay. Three to 6 h after the last treatment
for positive control group or 22 to 26 h after the last ex-
posure for air control and Graphistrength© C100 exposed
groups, the lung (left lobe used for BALF), the kidney
(caudal part) and the liver (middle lobe) were collected
from each animal and maintained in cold mincing buffer
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(Mg2+ and Ca2+ free Hanks’ Balanced Salt Solution (Gibco,
CA, USA) with 20 mM Na EDTA (EDTA) (Sigma, USA)
and 10 % (v/v) dimethylsulfoxide (DMSO) (Sigma)). Im-
mediately after dissection, the organs were minced using
fine scissors in cold mincing buffer. The cell suspension
was stored on ice for 15-30 s to allow large clumps to set-
tle, and the supernatant was used to prepare comet slides.
An aliquot of single cell suspension (3 x 104 cells) was
mixed per 75 μL of 0.5 % low melting agarose (Invitrogen,
USA) and spread on comet assay slides (Travigen, USA).
The slides were immersed in cold lysis solution (2.5 M
NaCl, 100 mM Na2EDTA, 10 mM Tris-base, 10 % DMSO,
1 % Triton-X (pH 10)) overnight. For the hOGG1-
modified comet assay, following lysis as described, slides
were washed two times for 5 min with the hOGG1 incu-
bation buffer (40 mM Hepes, 100 mM KCl, 0.5 mM
EDTA and 0.2 mg/mL BSA) at room temperature and
then incubated for 10 min at 37 °C with 0.12 x 10-3 U/slide
of hOGG1 (Biolabs) in the hOGG1 incubation buffer.
After this incubation period, slides were placed in electro-
phoresis solution (0.3 M NaOH, 1 mM EDTA (pH > 13))
for 20 min to allow for DNA unwinding. Subsequently,
electrophoresis was conducted at 25 V, 300 mA for
20 min. The slides were immersed in a neutralization
solution (0.4 M Tris-base, pH 7.5) for at least 5 min and
dehydrated with absolute ethanol to fix. The cells were
stained with propidium iodide (20 μg/mL) (Invitrogen). All
slides were independently coded before the microscopic
analysis. The comet was observed via fluorescence micro-
scope (Leica Microsystems SAS - DM 2000, Heerbrugg,
Switzerland) at magnification of x200 and analyzed by
COMETASSAY IV software (Perceptive Instruments, UK).
For each sample (animal/tissue), fifty comets per slide were
analyzed, with 3 slides scored per sample.
A positive response is defined as a statistically signifi-
cant change in the % tail DNA in at least one dose group
in comparison with the vehicle control value. The posi-
tive control should produce a statistically significant in-
crease. Cytotoxicity was evaluated by the enumeration of
hedgehogs. Indeed, important fragmentation of the DNA
can be induced not only by genotoxicity but also during
the process of cell death, i.e. apoptosis and necrosis.
Statistical analysis
The food consumption, blood pressure, grip strength,
landing foot play, body temperature, body weight, food con-
sumption, blood clinical laboratory and BALF parameters,
organ weights, and sperm parameters were analyzed for
statistical significance by the Dunnett-test (many to one t-
test) based on a pooled variance estimate, if the variables
can be assumed to follow a normal distribution for the
comparison of the treated groups and the control groups
for each sex. The Steel-test (many-one rank test) was ap-
plied for the locomotor activity, urinalysis, and BALF
biochemical parameters instead of the Dunnett-test when
the data cannot be assumed to follow a normal distribu-
tion. Fisher’s exact test was applied to the ophthalmoscopy
and macroscopic findings. Nonparametric Mann-Whitney
test was applied to the micronucleus, comet and to cyto-
kines test results as data did not follow a normal
distribution.
Additional file
Additional file 1: Figure S1. Electron microscopic images of
Graphistrength© C100 aerosols generated by the rotating brush
generator [16]. (A) TEM of the original material batch no. 6097,
Magnification: 135’000 fold. (B) and (C) TEM of aerosol samples.
Magnification: 135’000 fold. (D) SEM of aerosol sample, Magnification:
25’000 fold. Figure S2: Scanning (SEM) and transmission (TEM) electron
microscopic images of Graphistrength© C100 aerosols generated by the dust
disperser and collected directly into TEM grids. Millipore® durapore filter, Type
HVLP as used in the 5-day inhalation study. (A) SEM, Magnification: 2’000 fold.
(B) SEM, Magnification: 29’500 fold. (C) TEM, Magnification: 350’000 fold.
Figure S3: Particle size distribution after different milling durations of
Graphistrength© C100. Figure S4: Scanning (SEM) and transmission (TEM)
microscopic images of Graphistrength© C100 using the refined aerosol
generation procedure used during the 13-week exposure study. (A) TEM of
original Graphistrength© C100 batch no. 110329-018, 350’000 fold. (B) TEM of
milled Graphistrength© C100 under argon for 12 h and sieved (63 μm),
350’000 fold. (C) TEM of aerosol sample, 350’000 fold. (D) SEM of aerosol
sample, 50’000 fold. Figure S5: BALF parameters of male rats 24 h (A) and
4 weeks (B) after a 5-day exposure to Graphistrength© C100. Changes are
shown as x-fold differences compared to controls using a logarithmic scaling.
Abbreviations: ALP: alkaline phosphatase, GGT: γ-Glutamyltransferase, LDH:
lactate dehydrogenase. Figure S6: Microscopic appearance of lungs around
terminal bronchiole in rats after a 5-day exposure to Graphistrength© C100
(A) Control. (B) Graphistrength© C100, 1.30 mg/m3, after a 5-day inhalation
exposure: Terminal bronchiolar epithelium showing hypertrophic appearance
(asterisks). No inflammatory and granulomatous lesions are found. (C)
Graphistrength© C100, 1.30 mg/m3, after a 5-day inhalation exposure: Blackish
particle laden alveolar macrophages (arrows). (D) Graphistrength© C100,
1.30 mg/m3, after a 4-week recovery period: Histologic appearance of
the bronchiolar epithelium recovered partially. Original lens magnification:
(A), (B) and (D) Magnification: 10 fold; (C) Magnification: 40 fold. Table S1:
Oxygen surface content by XPS in Graphistrength© C100 aerosols from the
rotating brush dust generator [16]. Table S2: Effect by XPS of the milling
duration and milling atmosphere (air or argon) on the oxygen surface
content in Graphistrength© C100. Table S3: Physico-chemical
characterization of Graphistrength© C100 before and after aerosol
generation. Table S4: Target and achieved aerosol concentrations and
particles size of Graphistrength© C100. Temperature, relative humidity and
oxygen concentration measured over the 5-day exposure study. Table S5:
Cellular analysis of BALF of male rats 24 h and 4 weeks after a 5-day
exposure to Graphistrength© C100. Table S6: Biochemical analysis of BALF
of male rats 24 h and 4 weeks after a 5-day exposure to Graphistrength©
C100. Table S7: Main microscopic findings in the lungs of male and female
rats 24 h and 4 weeks after a 5-day exposure to Graphistrength© C100.
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Care; ALP: Alkaline phosphatase; BALF: Broncho-alveolar lavage fluid;
BET: Brunauer, Emmett and Teller (method); BSA: Bovine serum albumin;
CCL2: Chemokine ligand 2; CCL5: Chemokine (C-C motif) ligand 5;
CMAD: Count median aerodynamic diameter; CPA: Cyclophosphamide;
CXCL2: Macrophage inflammatory protein-2; DMEM: Dulbecco’s modified
Eagle medium; DNA: Deoxyribonucleic acid; ESCA: Electron spectroscopy for
chemical analysis; FPG: Formamidopyrimidine DNA glycosylase; GGT:
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control data; hOGG1: Human 8-hydroxyguanine DNA-glycosylase;
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